Genomics and Allergic Problems

Published Online: Monday, March 10, 2014
Follow Pharmacy_Times:
In this podcast, Osamu Ohara, PhD, of the laboratory of immunogenetics at RIKEN Research Center for Allergy and Immunology in Kanagawa, Japan, talks about the potential of functional genomics in the treatment of allergic diseases.

To listen to this podcast, click here.
Related Articles
The majority of patients who require inhalers for asthma or epinephrine autoinjectors for allergic disease for do not use the devices properly.
Many patients who claim to have penicillin allergies may not actually be allergic to the antibiotic.
Mylan Inc. today announced it has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening allergic reaction. The agreement includes updated maps in Disney's domestic theme parks and on its cruise ships as well as updated signage in the parks that highlight locations with EpiPen® and EpiPen Jr® Auto-Injectors. Over time, the companies also will introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.
Latest Issues
$auto_registration$